PedAM
Pediatric Disease Annotations & Medicines
| Disease | polycystic ovary syndrome |
| Phenotype | C0028754|obesity |
| Sentences | 19 |
| PubMedID- 22844280 | The most frequently anovulatory cycles are related to polycystic ovary syndrome (pcos) commonly associated with obesity and hormonal disturbances in the course of obesity. |
| PubMedID- 26123797 | Introduction: polycystic ovary syndrome (pcos) is associated with obesity and insulin resistance. |
| PubMedID- 21197149 | Pharmacological treatment of obesity in patients with polycystic ovary syndrome. |
| PubMedID- 20618344 | Objective: obesity is frequently associated with the polycystic ovary syndrome (pcos) and both conditions may impact on the health-related quality of life (hr-qol) of affected patients. |
| PubMedID- 25880805 | Background: polycystic ovary syndrome (pcos) is associated with obesity and increased cardiovascular (cv) risk markers. |
| PubMedID- 21283731 | Fto and mc4r gene variants are associated with obesity in polycystic ovary syndrome. |
| PubMedID- 26464861 | In addition, obesity is highly associated with polycystic ovary syndrome and increases some of its features like hyperandrogenism, hirsutism, and infertility [75]. |
| PubMedID- 25364674 | polycystic ovary syndrome is another cause of obesity and insulinoresistance in women too. |
| PubMedID- 24534286 | Conclusion(s): although polycystic ovary syndrome is associated with metabolic risk, obesity was the major determinant of cardiometabolic disturbances in reproductive-aged women. |
| PubMedID- 24742124 | Context: central obesity in polycystic ovary syndrome (pcos) is associated with increased inflammatory markers and increased risk for type 2 diabetes. |
| PubMedID- 24906976 | Context: central obesity in polycystic ovary syndrome (pcos) is associated with increased inflammatory markers and increased risk for type 2 diabetes. |
| PubMedID- 25634659 | A forest plot for the correlation of thetnf-alpha (−308 g/a)polymorphism with obesity in patients with polycystic ovary syndrome (bmi ≥ 25 kg/m2vs. |
| PubMedID- 25873949 | polycystic ovary syndrome (pcos) is associated with obesity and insulin resistance (ir), key features of nonalcoholic steatohepatitis (nash). |
| PubMedID- 26024975 | Increasing evidence suggests that non-alcoholic fatty liver disease (nafld) and polycystic ovary syndrome (pcos) are associated with obesity, insulin resistance, metabolic syndrome, cardiovascular disease, cirrhosis, and liver tumors. |
| PubMedID- 21756079 | Pioglitazone reduces central obesity in polycystic ovary syndrome women. |
| PubMedID- 25881575 | The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome. |
| PubMedID- 24479991 | Poor quality diet is associated with overweight status and obesity in patients with polycystic ovary syndrome. |
| PubMedID- 23218400 | Association between inflammatory biomarker serum procalcitonin and obesity in women with polycystic ovary syndrome. |
| PubMedID- 26188231 | Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome. |
Page: 1